Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.4423
-0.0008 (-0.18%)
At close: Sep 12, 2025, 4:00 PM EDT
0.4422
-0.0002 (-0.03%)
After-hours: Sep 12, 2025, 6:55 PM EDT
RVPH Employees
Reviva Pharmaceuticals Holdings had 14 employees as of December 31, 2024. The number of employees decreased by 1 or -6.67% compared to the previous year.
Employees
14
Change (1Y)
-1
Growth (1Y)
-6.67%
Revenue / Employee
n/a
Profits / Employee
-$1,936,552
Market Cap
30.08M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14 | -1 | -6.67% |
| Dec 31, 2023 | 15 | 5 | 50.00% |
| Dec 31, 2022 | 10 | 5 | 100.00% |
| Dec 31, 2021 | 5 | 0 | - |
| Dec 31, 2020 | 5 | 1 | 25.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RVPH News
- 4 weeks ago - Reviva Reports Second Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering - GlobeNewsWire
- 2 months ago - Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering - GlobeNewsWire
- 3 months ago - Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - GlobeNewsWire
- 3 months ago - Reviva Announces Positive Full Dataset for 1-Year Phase 3 RECOVER Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia - GlobeNewsWire
- 4 months ago - Reviva Reports First Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 5 months ago - Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress - GlobeNewsWire
- 7 months ago - Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire